Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q3MHH2

Entry ID Method Resolution Chain Position Source
AF-Q3MHH2-F1 Predicted AlphaFoldDB

123 variants for Q3MHH2

Variant ID(s) Position Change Description Diseaes Association Provenance
rs472468226 9 A>E No EVA
rs384759850 11 T>N No EVA
rs467729121 18 G>R No EVA
rs382769376 29 G>D No EVA
rs437466222 43 V>G No EVA
rs469138585 76 G>S No EVA
rs483076763 77 E>* No EVA
rs458235967 77 E>A No EVA
rs465134402 106 S>A No EVA
rs446627370 109 V>G No EVA
rs466913890 117 G>R No EVA
rs481218160 124 F>Y No EVA
rs451086496 128 A>S No EVA
rs478499978 137 A>T No EVA
rs459119267 150 E>K No EVA
rs459832650 155 W>G No EVA
rs441370326 158 F>I No EVA
rs474179295 161 V>E No EVA
rs455744550 168 I>N No EVA
rs439852996 174 H>P No EVA
rs472707335 174 H>Q No EVA
rs454135800 175 G>E No EVA
rs475055031 176 N>K No EVA
rs464129086 177 Y>* No EVA
rs437719331 177 Y>F No EVA
rs456190640 177 Y>H No EVA
rs452033415 179 V>F No EVA
rs433817322 180 Y>F No EVA
rs448434089 181 V>A No EVA
rs466880670 181 V>L No EVA
rs481212471 182 Q>K No EVA
rs450130238 188 I>F No EVA
rs483205090 190 S>R No EVA
rs458093054 212 G>A No EVA
rs454543010 229 E>G No EVA
rs436226522 249 Q>H No EVA
rs457271511 250 L>S No EVA
rs432168629 251 L>I No EVA
rs465195964 252 K>* No EVA
rs434066191 277 G>E No EVA
rs449930142 286 C>* No EVA
rs457879964 289 V>L No EVA
rs438893919 290 W>* No EVA
rs478304048 292 T>R No EVA
rs441234358 299 T>A No EVA
rs474256470 303 L>F No EVA
rs443929177 305 Q>H No EVA
rs476807290 308 S>R No EVA
rs451833530 310 Q>H No EVA
rs459482610 352 G>C No EVA
rs459482610 352 G>S No EVA
rs471457558 359 F>C No EVA
rs452479247 361 N>S No EVA
rs434060099 380 R>* No EVA
rs517713268 393 P>S No EVA
rs134045444 399 T>R No EVA
rs459691584 401 L>H No EVA
rs478158060 401 L>V No EVA
rs448919073 403 A>T No EVA
rs483147408 408 D>E No EVA
rs458312700 411 K>* No EVA
rs479306767 415 V>L No EVA
rs714079633 418 R>H No EVA
rs460194971 428 D>G No EVA
rs441716084 431 T>P No EVA
rs474565561 432 I>M No EVA
rs456151411 437 I>M No EVA
rs444312775 448 P>Q No EVA
rs470867384 450 F>C No EVA
rs452452349 451 Y>H No EVA
rs208897965 453 C>R No EVA
rs454100452 454 N>S No EVA
rs435685975 464 V>A No EVA
rs444022443 477 A>P No EVA
rs470628203 480 K>T No EVA
rs440296108 482 D>E No EVA
rs452415057 482 D>H No EVA
rs473129628 483 V>M No EVA
rs454737085 484 Q>K No EVA
rs435645619 485 I>N No EVA
rs435645619 485 I>T No EVA
rs456523368 488 L>P No EVA
rs437950728 490 L>P No EVA
rs464404045 492 Q>K No EVA
rs446258748 493 F>L No EVA
rs434297849 497 P>S No EVA
rs448651787 499 S>* No EVA
rs481701018 506 K>E No EVA
rs462642078 506 K>N No EVA
rs450659328 507 V>F No EVA
rs458529709 508 F>V No EVA
rs448781670 515 T>S No EVA
rs481654503 517 Q>* No EVA
rs469907372 517 Q>L No EVA
rs445138958 525 S>* No EVA
rs478003622 526 V>A No EVA
rs440461298 533 V>G No EVA
rs799361930 535 D>N No EVA
rs479977674 548 G>V No EVA
rs457272948 560 A>G No EVA
rs443571122 565 E>* No EVA
rs109223030 570 A>T No EVA
rs442821744 573 E>D No EVA
rs456317013 596 S>I No EVA
rs470276650 597 E>A No EVA
rs437826665 597 E>Q No EVA
rs468700230 614 L>P No EVA
rs797966385 629 N>T No EVA
rs474777210 658 T>A No EVA
rs456362705 663 I>R No EVA
rs438016473 666 A>E No EVA
rs464864949 668 R>G No EVA
rs434132149 671 L>F No EVA
rs467171613 673 L>P No EVA
rs525047324 674 Y>* No EVA
rs452731639 681 I>L No EVA
rs467134512 689 K>M No EVA
rs455111612 689 K>N No EVA
rs436612986 694 F>L No EVA
rs469065223 695 R>C No EVA
rs450540166 695 R>H No EVA
rs476997027 698 Q>H No EVA
rs464926765 699 K>* No EVA

No associated diseases with Q3MHH2

1 regional properties for Q3MHH2

Type Name Position InterPro Accession
domain CCAAT-binding factor 297 - 446 IPR005612

Functions

Description
EC Number
Subcellular Localization
  • Nucleus, nucleolus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
nucleolus A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
t-UTP complex A protein complex that forms a subcomplex of the 90S preribosome and is required for the subsequent assembly of the rest of the preribosome. In S. cerevisiae, it is composed of Utp5p, Utp4p, Nan1p, Utp8p, Utp9p, Utp10 and Utp15p.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

2 GO annotations of biological process

Name Definition
maturation of SSU-rRNA Any process involved in the maturation of a precursor Small SubUnit (SSU) ribosomal RNA (rRNA) molecule into a mature SSU-rRNA molecule.
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I Any process that activates or increases the frequency, rate or extent of transcription of nuclear large rRNA mediated by RNA polymerase I.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5ZL79 NOL11 Nucleolar protein 11 Gallus gallus (Chicken) PR
Q9H8H0 NOL11 Nucleolar protein 11 Homo sapiens (Human) PR
10 20 30 40 50 60
MADLEEGFAL TAVPLGSGPD GPLGVEQSGK TDQFLVTDSG RTVILYKVSD QKPLGSWSVK
70 80 90 100 110 120
QGQIITCPAV CNFQTGEYIV VHDNKVLRIW NNEDVNLDKV FKATLSAEVY RIHSIQGTEP
130 140 150 160 170 180
LVLFKEGAVR GLEALLAEPQ QKIETVISDE EVIKWTKFFM VFRHPVLIFI TEKHGNYFVY
190 200 210 220 230 240
VQKFNSRILS KYTLLLGQEE KCVIQSFSTS VGRKFISLMS LSSDGCVYET LIPIHPSEPE
250 260 270 280 290 300
KNQRLVQSQL LKSVVSGSAR NGVALAILDQ DHIAVLGAPL PASKECLSVW NTKFQTLQTS
310 320 330 340 350 360
KELPQGTSGQ LWYYGENLFM LHGKFLTVVP FKCEVSSLAG ALGKLKHSQD PGIHATPHFV
370 380 390 400 410 420
NWETSQGCGL GSQNSEQSKR ILRRRKVEVS VQPEVPASTQ LLATIQKDSE KHIEVELRKF
430 440 450 460 470 480
LATKRTPDFH TIIGDVIIGL LGRCKAEPSF YPCNCLMQLV QTHVLSYSLC PGLMEFALEK
490 500 510 520 530 540
TDVQILQLCL QQFPDIPESV TCACLKVFLS IGDDTLQDTD INMESVSDYM DPVQDGEMEE
550 560 570 580 590 600
QTAFLQNGFS PEEDNCDSCA QKLKEKPQAA ADESTSCPVT PKRAALLNAV LHSAYSETFL
610 620 630 640 650 660
LPHLKDIPAQ HSTLFLQYLY FLYLKCSENA TMTLPGTHPP TLSQIMDWIC LLLDANFTVV
670 680 690 700 710
VMIPEAKRLL LSLYKFVKSQ ISICSELNKI EVSFRELQKL NQEKNNRELY SIEVLELF